Biggest News Aggregation in the World
📰 Patient Program News

Page 12 - Patient Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patient Program. Real-time updates on events, politics, business and more.

LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

30.03.2022 - Phase 3 registrational trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) ongoing Mavacamten granted breakthrough therapy designation in China for the treatment of patients with oHCM ...
Hainan Province Susan Silbermann Jesse Wu Michael Humphries Bristol Myers Squibb Yizhe Wang

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

- XPOVIO® (selinexor) approvals received in Mainland China, Australia, South Korea and Singapore, expect Hong Kong and Taiwan in remainder of 2022. - 2021 Revenue of RMB28.8 million, Named Patient Program paving way for strong commercial launch in 2022. - Broad and deep clinical program of 18 studies, including 5 registrational studies, ongoing across multiple regions. - Strong cash,...
United States Hong Kong South Korea Jay Mei Asia Pacific Peter Qian

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science